Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanil Bhatia

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Hemasphere|June 12, 2023
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic LeukemiaChiara Palmi, Silvia Bresolin, Stefanie Junk, et al.
Leukemia|April 29, 2025
The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cellsAndreas O Mieland, Giuseppe Petrosino, Mario Dejung, et al.
Journal of Medicinal Chemistry|November 27, 2024
Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant LeukemiaFabian Fischer, Julian Schliehe-Diecks, Jia-Wey Tu, et al.
Ebiomedicine|August 19, 2022
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120Grazia Fazio, Silvia Bresolin, Daniela Silvestri, et al.
ACS Central Science|June 1, 2022
Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 DimerizationSanil Bhatia, Lukas Spanier, David Bickel, et al.
Blood|September 10, 2020
An intact gut microbiome protects genetically predisposed mice against leukemiaCarolina Vicente-Dueñas, Stefan Janssen, Marina Oldenburg, et al.
Hemasphere|April 3, 2025
H1-0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemiaVera H Jepsen, Andrea Hanel, Daniel Picard, et al.
EMBO Molecular Medicine|March 14, 2025
Immune training enhances anti-viral responses and improves outcomes in Pax5<sup>-/+</sup> mice susceptible to chronic infectionZhe Lu, Olivia Stencel, Wei Liu, et al.
International Journal of Molecular Sciences|May 14, 2022
Recurrent Germline Variant in <i>RAD21</i> Predisposes Children to Lymphoblastic Leukemia or LymphomaAnne Schedel, Ulrike Anne Friedrich, Mina N F Morcos, et al.
Blood|May 5, 2018
Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock responseSanil Bhatia, Daniela Diedrich, Benedikt Frieg, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Hemasphere|June 12, 2023
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic LeukemiaChiara Palmi, Silvia Bresolin, Stefanie Junk, et al.
Leukemia|April 29, 2025
The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cellsAndreas O Mieland, Giuseppe Petrosino, Mario Dejung, et al.
Journal of Medicinal Chemistry|November 27, 2024
Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant LeukemiaFabian Fischer, Julian Schliehe-Diecks, Jia-Wey Tu, et al.
Ebiomedicine|August 19, 2022
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120Grazia Fazio, Silvia Bresolin, Daniela Silvestri, et al.
ACS Central Science|June 1, 2022
Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 DimerizationSanil Bhatia, Lukas Spanier, David Bickel, et al.
Blood|September 10, 2020
An intact gut microbiome protects genetically predisposed mice against leukemiaCarolina Vicente-Dueñas, Stefan Janssen, Marina Oldenburg, et al.
Hemasphere|April 3, 2025
H1-0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemiaVera H Jepsen, Andrea Hanel, Daniel Picard, et al.
EMBO Molecular Medicine|March 14, 2025
Immune training enhances anti-viral responses and improves outcomes in Pax5<sup>-/+</sup> mice susceptible to chronic infectionZhe Lu, Olivia Stencel, Wei Liu, et al.
International Journal of Molecular Sciences|May 14, 2022
Recurrent Germline Variant in <i>RAD21</i> Predisposes Children to Lymphoblastic Leukemia or LymphomaAnne Schedel, Ulrike Anne Friedrich, Mina N F Morcos, et al.
Blood|May 5, 2018
Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock responseSanil Bhatia, Daniela Diedrich, Benedikt Frieg, et al.
Pageof 6